Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Shingrix second dose never administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on 15-APR-2019 with batch number 4X733 and expiry date 08 March 2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Shingrix second dose never administered). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 05-JUN-2025 The Vaccine Administration Facility was the same as Primary Reporter On 5 June 2025, a pharmacist called on behalf of a patient for asking how to proceed on a Shingrix second dose never administered. The patient asked his doctor about getting the complete doses again and wanted it to be confirmed by the manufacturer. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.